RayKnowChina Research Map
Shortlist

Beijing

Fuwai Hospital

中国医学科学院阜外心血管病医院

Listed for 5 of the 53 diseases this site covers, from the research papers it led and the trials registered with it as lead sponsor or site.

Research activity in public records, not a rating of care. Whether the hospital can help a particular patient is for the hospital and the treating doctor to say.

No official website checked for this hospital yet.

Getting in touch

Research at Fuwai Hospital

Choose a disease to see the papers and trials behind it. Each tile shows papers led, 2021–2025, and papers per year.

Only the 53 diseases this site covers. A disease it is not listed for means this hospital did not meet the listing rule for that disease in these records; it does not mean the hospital does not treat it. Which hospitals are listed

  1. Neuroblastoma神经母细胞瘤1 paper led
  2. Haemophilia A血友病 A1 paper led
  3. Takayasu arteritis大动脉炎13 papers led
  4. Fabry disease法布雷病1 paper led1 open trial led
  5. Behçet disease白塞病4 papers led

Not listed for: Nasopharyngeal carcinoma, Oesophageal squamous cell carcinoma, Hepatocellular carcinoma, Stomach cancer, Hepatoblastoma, Retinoblastoma, Chordoma, Osteosarcoma, Gastrointestinal stromal tumour, Ewing sarcoma, Multiple myeloma, B-cell acute lymphoblastic leukaemia, Aplastic anaemia, Haemophagocytic lymphohistiocytosis, Beta thalassaemia, Atypical haemolytic uraemic syndrome, Thrombotic thrombocytopenic purpura, Fanconi anaemia, Neuromyelitis optica spectrum disorder, IgG4-related disease, Myasthenia gravis, Moyamoya disease, Wilson disease, Biliary atresia, Anti-NMDA receptor encephalitis, Hepatic echinococcosis, Idiopathic pulmonary fibrosis, Lymphangioleiomyomatosis, Amyotrophic lateral sclerosis, Spinal muscular atrophy, Pompe disease, Duchenne muscular dystrophy, Alport syndrome, IgA nephropathy, Gaucher disease, Niemann–Pick disease type C, Osteogenesis imperfecta, Primary biliary cholangitis, Primary sclerosing cholangitis, Congenital diaphragmatic hernia, Hirschsprung disease, Inherited epidermolysis bullosa, Hereditary angioedema, Familial adenomatous polyposis, Leber hereditary optic neuropathy, Majeed syndrome, NGLY1 deficiency, ISG15 deficiency.

Cancer

Neuroblastoma

神经母细胞瘤

Led 1 of the 1,132 English-language PubMed papers on neuroblastoma with an author in mainland China, 2021–2025: 0.09%.

Papers led
1
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 1120222023: 0020232024: 0020242025: 002025

24 hospitals in Beijing for neuroblastoma352 hospitals in China for neuroblastoma

No open trial on neuroblastoma lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers

Hospital name read automatically from author addresses, not yet checked by hand.

Run the PubMed searchClinicalTrials.gov

Blood disorders

Haemophilia A

血友病 A

Led 1 of the 272 English-language PubMed papers on haemophilia A with an author in mainland China, 2021–2025: 0.4%.

Papers led
1
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 1120212022: 0020222023: 0020232024: 0020242025: 002025

15 hospitals in Beijing for haemophilia A160 hospitals in China for haemophilia A

No open trial on haemophilia A lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers

Hospital name read automatically from author addresses, not yet checked by hand.

Run the PubMed searchClinicalTrials.gov

Other diseases

Takayasu arteritis

大动脉炎

Led 13 of the 187 English-language PubMed papers on Takayasu arteritis with an author in mainland China, 2021–2025: 7.0%.

Papers led
13
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
1
led by another institution
Papers led per year
2021: 4420212022: 3320222023: 5520232024: 0020242025: 112025

30 hospitals in Beijing for Takayasu arteritis108 hospitals in China for Takayasu arteritis

Open trials with this hospital 1

Recruiting, not yet recruiting, or by invitation on ClinicalTrials.gov on 13 Nov 2026. Trials registered only in China’s own registry (ChiCTR) are not included. Whether someone can take part is decided by the study team.

  1. Recruiting
    Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement
    Phase
    Not given
    Started
    2014-01
    Registry
    NCT05388682

    Age not stated (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

The records behind these numbers

Hospital name read automatically from author addresses, not yet checked by hand.

Papers it led13
  1. Endovascular Therapy for Supra-aortic Artery Stenosis Caused by Takayasu's Arteritis: Long Term Results.2025European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
  2. Alterations of Gut Microbiome, Metabolome, and Lipidome in Takayasu Arteritis.2023Arthritis & rheumatology (Hoboken, N.J.)
  3. Comparison of long-term survival after endovascular treatment versus medical therapy in patients with Takayasu's arteritis and pulmonary artery stenosis.2023Clinical and experimental rheumatology
  4. Angiographic classification of pulmonary vascular lesion in Takayasu arteritis: A cohort study.2023Respiratory medicine
  5. A single-center cohort of mid-aortic syndrome among adults in China: Etiology, presentation and imaging features.2023The American journal of the medical sciences
  6. Patient With Takayasu Arteritis Treated with the Ozaki Procedure and Ascending Aorta Replacement.2023The heart surgery forum
  7. Characteristics of four-limb blood pressure and brachial-ankle pulse wave velocity in Chinese patients with Takayasu arteritis.2022Blood pressure
  8. Long-term outcomes and prognostic predictors of patients with Takayasu's arteritis along with pulmonary artery involvement.2022Clinical and experimental rheumatology
  9. Long-Term Outcomes After Percutaneous Transluminal Pulmonary Angioplasty in Patients With Takayasu Arteritis and Pulmonary Hypertension.2022Frontiers in immunology
  10. Clinical Scenario and Long-Term Outcome of Childhood Takayasu Arteritis Undergoing 121 Endovascular Interventions: A Large Cohort Over a Fifteen-Year Period.2021Arthritis care & research
  11. 18F-FDG PET/CT plays a unique role in the management of Takayasu arteritis patients with atypical manifestations.2021Clinical rheumatology
  12. Elevated chemokines concentration is associated with disease activity in Takayasu arteritis.2021Cytokine
  13. Clinical characteristics and outcomes of chronic heart failure in adult Takayasu arteritis: A cohort study of 163 patients.2021International journal of cardiology
Chinese-language papers (not in the count)1
  1. [Impact of interventional therapy on top of standard drug therapy on left ventricular structure and function in HFrEF patients complicating with middle aortic syndrome caused by Takayasu arteritis].2022Zhonghua xin xue guan bing za zhi
Earlier papers (2016–2020)23
  1. Surgical Treatment in Patients With Aortic Regurgitation Due to Takayasu Arteritis.2020The Annals of thoracic surgery
  2. Clinical Course, Management, and Outcomes of Pediatric Takayasu Arteritis Initially Presenting With Hypertension: A 16-year overview.2019American journal of hypertension
  3. Clinical course and prognostic factors of childhood Takayasu's arteritis: over 15-year comprehensive analysis of 101 patients.2019Arthritis research & therapy
  4. Association between increased arterial stiffness measured by brachial-ankle pulse wave velocity and cardiovascular events in patients with Takayasu's arteritis.2019Clinical and experimental rheumatology
  5. Association of interleukin-6 and interleukin-10 expression, gene polymorphisms, and Takayasu arteritis in a Chinese Han population.2019Clinical rheumatology
  6. Endovascular Treatment of Iliac Artery Stenosis Caused by Takayasu Arteritis: A 10-Year Experience.2019Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
  7. [Clinical experience in the diagnosis and treatment of aortic stenosis caused by Takayasu arteritis in pediatric patients].2019Zhonghua xin xue guan bing za zhi
  8. Stenting for middle aortic syndrome caused by Takayasu arteritis-immediate and long-term outcomes.2018Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  9. The presentation and management of hypertension in a large cohort of Takayasu arteritis.2018Clinical rheumatology
  10. Time trends regarding the etiology of renal artery stenosis: 18 years' experience from the China Center for Cardiovascular Disease.2018Journal of clinical hypertension (Greenwich, Conn.)
  11. Cardiac Valve Involvement in Takayasu Arteritis Is Common: A Retrospective Study of 1,069 Patients Over 25 Years.2018The American journal of the medical sciences
  12. An unrecognised presentation of Takayasu arteritis: superficial femoral artery involvement.2017Clinical and experimental rheumatology
  13. Outcomes of percutaneous coronary intervention and coronary artery bypass grafting in patients with Takayasu arteritis.2017International journal of cardiology
  14. Long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention for Takayasu arteritis patients with coronary artery involvement.2017Seminars in arthritis and rheumatism
  15. Aortic Aneurysm in Takayasu Arteritis.2017The American journal of the medical sciences
  16. Aortic Dissection in Takayasu Arteritis.2017The American journal of the medical sciences
  17. Anaemia and low body mass index are associated with increased cardiovascular disease in patients with Takayasu arteritis.2016Clinical and experimental rheumatology
  18. High-sensitivity C-reactive protein predicts adverse cardiovascular events in patients with Takayasu arteritis with coronary artery involvement.2016Clinical rheumatology
  19. Serum C-reactive protein level but not its gene polymorphism is associated with Takayasu arteritis.2016Clinical rheumatology
  20. Lack of association between polymorphisms in interleukin (IL)-12, IL-12R, IL-23, IL-23R genes and Takayasu arteritis in a Chinese population.2016Inflammation research : official journal of the European Histamine Research Society ... [et al.]
  21. Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis: Two-year results.2016International journal of cardiology
  22. Etiology of renal artery stenosis in 2047 patients: a single-center retrospective analysis during a 15-year period in China.2016Journal of human hypertension
  23. [Clinical features of Takayasu arteritis patients with pulmonary hypertension due to pulmonary artery involvement].2016Zhonghua yi xue za zhi
All its trials on ClinicalTrials.gov, any status1
  1. Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery InvolvementRecruitingNCT05388682Study siteStart 2014-01

Run the PubMed searchClinicalTrials.gov

Other diseases

Fabry disease

法布雷病

Led 1 of the 73 English-language PubMed papers on Fabry disease with an author in mainland China, 2021–2025: 1.4%.

Papers led
1
2021–2025
Trials led
1
any status, ClinicalTrials.gov
Open trials led
1
recruiting or about to
Open trials as a site
1
led by another institution
Papers led per year
2021: 1120212022: 0020222023: 0020232024: 0020242025: 002025

11 hospitals in Beijing for Fabry disease85 hospitals in China for Fabry disease

Open trials with this hospital 2

Recruiting, not yet recruiting, or by invitation on ClinicalTrials.gov on 13 Nov 2026. Trials registered only in China’s own registry (ChiCTR) are not included. Whether someone can take part is decided by the study team.

  1. Recruiting
    Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques
    Phase
    Not given
    Started
    2010-01
    Registry
    NCT07336394

    Age not stated (registered criteria)

    Led by Fuwai Hospital; 1 listed hospital as study siteBeijing

  2. Recruiting
    CVI Alterations in FD: a Prospective, Multicenter, Observational Cohort Study
    Phase
    Not given
    Started
    2024-12
    Registry
    NCT06512571

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

The records behind these numbers

Hospital name read automatically from author addresses, not yet checked by hand.

Run the PubMed searchClinicalTrials.gov

Other diseases

Behçet disease

白塞病

Led 4 of the 245 English-language PubMed papers on Behçet disease with an author in mainland China, 2021–2025: 1.6%.

Papers led
4
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 2220232024: 1120242025: 112025

24 hospitals in Beijing for Behçet disease149 hospitals in China for Behçet disease

No open trial on Behçet disease lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersPediatricsRadiology / nuclear medicine

Hospital name read automatically from author addresses, not yet checked by hand.

Run the PubMed searchClinicalTrials.gov

Getting in touch

Name card to show staff or a driver

中国医学科学院阜外心血管病医院

Fuwai Hospital

北京

Large hospitals often have several campuses. Confirm the campus with the hospital before travelling.

Inquiry letter in English and Chinese

Fill in the brackets, then send it through the contact options on the hospital's international office or official website. Nothing typed here leaves this device.

Records hospitals usually ask for

  • A recent summary or letter from the treating doctor
  • Pathology report
  • Scans (CT, MRI, PET) with their reports, and the images if possible
  • Treatments so far, with dates
  • Current medicines

What to do next

Talk with the treating doctorThis page can be shared with the treating doctor to discuss whether this team's work is relevant.
Check the team is still therePapers lag by months and doctors move. Look for the department on the hospital's own website.
Contact the hospital directlyUse the hospital's own contacts. Hospitals never pay us, and each hospital decides which patients it accepts.

Where these numbers come from

Papers

English-language PubMed papers whose first or last author lists this hospital as their first affiliation, 2021–2025. Definitions

Trials

ClinicalTrials.gov records naming this hospital as lead sponsor or site, as of 8 Nov 2026.

Identifiers and other names

No hospital-level ROR record matched.

Suggest a correctionDownload the data